AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2011
Feb 10, 2011
34117_dirs_2011-02-10_63b5d25d-40e6-4836-a6ed-b207beabbcc6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-02-08
Reporting Person: Titterton Lewis H jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-02-08 | Common Stock | P | 1400000 | $0.1786 | Acquired | 6746562 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-02-08 | Common Stock Purchase Warrants (Right to Buy) | $0.1786 | P | 1400000 | Acquired | 2016-02-08 | Common Stock (1400000) | Direct |
Footnotes
F1: On February 8, 2011, Mr. Titterton Jr. purchased 1,400,000 shares of Common Stock, par value $0.01 and 1,400,000 Warrants to purchase Common Stock for an aggregate purchase price of $250,000 from CopyTele, Inc. in a private placement.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6